Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial

IMPORTANCE: Clinical outcomes after curative treatment of resectable pancreatic ductal adenocarcinoma (PDA) remain suboptimal. To assess the potential of early control of systemic disease with multiagent perioperative chemotherapy, we conducted a prospective trial. OBJECTIVE: To determine 2-year ove...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Oncol
Glavni autori: Sohal, Davendra P. S., Duong, Mai, Ahmad, Syed A., Gandhi, Namita S., Beg, M. Shaalan, Wang-Gillam, Andrea, Wade, James L., Chiorean, E. Gabriela, Guthrie, Katherine A., Lowy, Andrew M., Philip, Philip A., Hochster, Howard S.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2021
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7821078/
https://ncbi.nlm.nih.gov/pubmed/33475684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.7328
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items